United States· US:62032-610_ec9ff793-4459-48ad-94e6-11bbcd8dfe56
CLENZIDERM DAILY CARE FOAMING CLEANSER
A salicylic acid product containing salicylic acid, registered in United States by Obagi Cosmeceuticals LLC. The same ATC class is registered in 6 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Salicylic acid is registered in 6 of 19 countries.
Countries holding a registration under ATC D01AE12 (salicylic acid), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 2 of them publish a price we can compare per daily dose
Salicylic acid · ATC D01AE12
6 / 19 countries
- Belgiumprice
- Germany
- Ireland
- Japan
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- SALICYLIC ACID
- Manufacturer
- Obagi Cosmeceuticals LLC
- Country
- United States (US)
- ATC code
- D01AE12
- ATC class
- Salicylic acid
- Defined daily dose
- 0.3 g, T
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc116203261011118 mL in 1 BOTTLE, PLASTIC (62032-610-11)
- ndc1162032610501000 mL in 1 BOTTLE, PLASTIC (62032-610-50)
- ndc1162032-610-11
- ndc1162032-610-50
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
229 interactions on record for salicylic acid.
Graded by severity as the source publishes them — 16 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Salicylic acid · interactions on record
229 records
- 16 severe
- 182 moderate
- 31 minor
Most severe, free to view
- MethotrexateL01BA01severe
- RamucirumabL01FG02severe
- RamucirumabL01XC21severe
- LeflunomidL04AA13severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under D01AE12
Salicylic acid, as other registers publish it.
- United States111MedCo 2% Salicylic Acid Cleansing Bar111MedCo LLC
- United States24 PK BLEMISH DOTGanzhou Olivee Cosmetic Co., Ltd.
- United States24 PK BLEMISH DOTGanzhou Olivee Cosmetic Co., Ltd.
- United States24 PK BLEMISH DOTGanzhou Olivee Cosmetic Co., Ltd.
- United States7 Day Spot and Tag Remover PenGuangxi Keyun E-commerce Co., Ltd.
- United StatesAAVRANI DRY SCALP RESCUE SERUMAAVRANI, INC.
- United StatesAbib Acne foam cleanser Heartleaf foamFourcompany Co., Ltd.
- United StatesAcne Advanced Clarifying HydratorEminence Organic Skin Care Ltd.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ff26eb2f-4e11-484f-80a1-7f4c1aee4232 GET /v1/drugs/ff26eb2f-4e11-484f-80a1-7f4c1aee4232?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "20",
"substance": "SALICYLIC ACID",
"productndc": "62032-610",
"dosage_form": "LIQUID",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "M006",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about salicylic acid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.